Denmark could help more patients with Wegovy cost if Novo pays too -minister
Reuters· 7 日前Denmark's government could help cover the cost of hugely popular weight-loss drug ... ...
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages ...
CNBC· 3 日前Eli Lilly on Tuesday said its recently approved weight loss treatment Zepbound is now available at pharmacies ...
How a bold $60 bln deal went right yet so wrong
Reuters· 2 日前Like the quest to discover a new medicine, pulling off a successful ...
Investors Can’t Help Gorging on Anti-Obesity Drugs
Bloomberg· 4 日前Investors’ appetite for obesity treatments is proving hard to satisfy. Swiss pharmaceuticals ...
Competition will make obesity drugs successful
Reuters· 7 日前In an interview with the Financial Times, he proposed spreading reimbursements over time if .. ...
Eli Lilly vs. Novo Nordisk: The pros deliver their verdict on the viral weight-loss stocks ...
CNBC· 3 日前It has been quite a year for both Eli Lilly and Novo Nordisk given the boom in weight-loss ... ...
First CRISPR Sickle Cell Patient ‘Reborn’: FDA Approval Expected
Forbes· 3 日前Victoria Gray never remembers a moment when she didn’t have sickle cell disease. For Gray, who ...
Wednesday's analyst calls: Burger stock upgrade, auto racing name a top 2024 idea
CNBC· 2 日前Raymond James raised its rating on the stock to strong buy from outperform, citing ...
Governors Urge Biden To Reschedule Marijuana By The End Of This Year
Forbes· 2 日前The governors of six states have jointly written a letter to President Joe Biden, ...
Roche Will Buy Obesity And Diabetes Drugmaker Carmot Therapeutics In $2.7 Billion Deal
Forbes· 4 日前... which develops anti-obesity and diabetes drugs, for $2.7 billion, according to a press rel ...
